Xponance’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $323K | Buy |
14,842
+2,342
| +19% | +$45.3K | ﹤0.01% | 1223 |
|
|
2025
Q4 | $269K | Buy |
12,500
+555
| +5% | +$11.7K | ﹤0.01% | 1235 |
|
|
2025
Q3 | $230K | Sell |
11,945
-5,950
| -33% | -$106K | ﹤0.01% | 1290 |
|
|
2025
Q2 | $306K | Sell |
17,895
-1,426
| -7% | -$60.8K | ﹤0.01% | 1137 |
|
|
2025
Q1 | $1.23M | Buy |
19,321
+608
| +3% | +$64K | 0.01% | 629 |
|
|
2024
Q4 | $2.28M | Buy |
18,713
+571
| +3% | +$70K | 0.02% | 494 |
|
|
2024
Q3 | $2.27M | Sell |
18,142
-404
| -2% | -$55.9K | 0.02% | 487 |
|
|
2024
Q2 | $2.93M | Buy |
18,546
+7,106
| +62% | +$913K | 0.03% | 415 |
|
|
2024
Q1 | $1.48M | Sell |
11,440
-288
| -2% | -$35.3K | 0.02% | 607 |
|
|
2023
Q4 | $1.13M | Sell |
11,728
-882
| -7% | -$84.6K | 0.01% | 627 |
|
|
2023
Q3 | $1.53M | Buy |
12,610
+72
| +0.6% | +$8.14K | 0.02% | 532 |
|
|
2023
Q2 | $1.44M | Buy |
12,538
+1,051
| +9% | +$136K | 0.02% | 549 |
|
|
2023
Q1 | $1.58M | Buy |
11,487
+93
| +0.8% | +$12.1K | 0.02% | 517 |
|
|
2022
Q4 | $1.48M | Buy |
11,394
+1,477
| +15% | +$171K | 0.02% | 518 |
|
|
2022
Q3 | $1.1M | Buy |
9,917
+54
| +0.5% | +$5.44K | 0.02% | 548 |
|
|
2022
Q2 | $739K | Buy |
9,863
+479
| +5% | +$35.2K | 0.01% | 689 |
|
|
2022
Q1 | $733K | Buy |
9,384
+52
| +0.6% | +$3.98K | 0.01% | 719 |
|
|
2021
Q4 | $840K | Buy |
9,332
+772
| +9% | +$66K | 0.01% | 681 |
|
|
2021
Q3 | $792K | Sell |
8,560
-345
| -4% | -$26.6K | 0.02% | 669 |
|
|
2021
Q2 | $692K | Buy |
8,905
+1,095
| +14% | +$83K | 0.01% | 763 |
|
|
2021
Q1 | $582K | Sell |
7,810
-11
| -0.1% | -$1.01K | 0.01% | 707 |
|
|
2020
Q4 | $1.33M | Buy |
7,821
+88
| +1% | +$13K | 0.03% | 395 |
|
|
2020
Q3 | $1.09M | Sell |
7,733
-39
| -0.5% | -$5.93K | 0.03% | 396 |
|
|
2020
Q2 | $1.25M | Buy |
+7,772
| New | +$1.06M | 0.03% | 340 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
